Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Music
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/ef/6c/0c/ef6c0c29-67a2-6e8a-c78c-dcbce42d0b62/mza_18158127396448571704.png/600x600bb.jpg
#SynBio Podcast
iGEM
10 episodes
5 days ago
The Synbio Audio Storytelling Platform.
Show more...
Science
RSS
All content for #SynBio Podcast is the property of iGEM and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Synbio Audio Storytelling Platform.
Show more...
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/36619425/3014c6a0fcc2c99a.jpeg
S1E7 | Life. Science. Venture |Miroslav Gasparek
#SynBio Podcast
35 minutes 44 seconds
4 years ago
S1E7 | Life. Science. Venture |Miroslav Gasparek

Miroslav Gasparek is a PhD candidate in engineering science at Oxford University. He’s also a venture fellow at Civilisation ventures, and part of the steering committee at the European Union SynBio society. 

Miro’s research lies at the intersection of SynBio, control theory and data-driven control methods like reinforcement learning. He’s interested in the practical applications of SynBio, its wider impact and providing solutions to real-life problems. As well as understanding how meaningful and live-saving innovations get to the market.

Topics explored in this week's episode:

-How does a life scientist get interested in Venture Capital?

-How to formally analyse an investment opportunity in Synthetic Biology

-Why are there more challenges for raising capital for SynBio companies in Europe when compared to the US?

-Miro’s research journey as well as Fellowship experience at Newton Ventures and Civilisation Ventures.

Miro's website: https://www.miroslavgasparek.com/pages/about.html

#SynBio Podcast
The Synbio Audio Storytelling Platform.